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Abstract
Our aim was to clarify the effect of a somatostatin analogue (octreotide) on glucose flux
in conscious dogs. We monitored the effects with catheters in the portal vein, hepatic vein and
femoral artery and Doppler flow probes on the portal vein and hepatic artery before and after
oral glucose administration. A significant increase of portal vein plasma flow after oral glucose
was completely suppreed by both 4 and 1 µg/kg octreotide. All doses of octreotide (4, 1 and
0.1 µg/kg) suppreed the glucose-induced increment of arterial glucose by dose response. Only 4
µg/kg of octreotide slightly but significantly suppreed hepatic glucose output. Marked suppreion
and delayed glucose absorption by the intestine was observed after 4 µg/kg of octreotide. One and
0.1 µg/kg octreotide also suppreed glucose absorption without delayed absorption. Total amounts
of absorbed glucose during 3h after oral glucose were 24 ± 11% with 4 µg/kg of octreotide, 37
± 16% with 1 µg/kg of octreotide, and 48 ± 8% with 0.1 µg/ kg of octreotide, all of which were
significantly le than that of the control (73 ± 8%). Using 4 µg/kg of octreotide treatment, the
liver took up only 5 ± 4% of the absorbed glucose, while the liver took up 35 ± 6% and 43 ±
9% of the absorbed glucose with 1 and 0.1 µg/kg of octreotide. These latter values were similar
to that of the control value of 34 ± 4%. In conclusion, we found that octreotide administered
before oral glucose had a remarkable stabilizing effect on postprandial glycemic surges. Both the
direct inhibitory effect of octreotide on portal vein plasma flow and impaired glucose absorption
would contribute to this decreased postprandial hyperglycemia, while its suppreive effect on other
hormones, such as insulin and glucagon, did not seem to influence the reduction of hyperglycemia.
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